New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 14, 2014
10:14 EDTBANC, PPC, TKC, TEVA, SIGI, NSH, NS, LOW, INDB, TESOOn The Fly: Analyst Upgrade Summary
Banc of California (BANC) upgraded to Buy from Neutral at Sterne Agee... Independent Bank (INDB) upgraded to Outperform from Market Perform at Keefe Bruyette... Lowe's (LOW) upgraded to Outperform from Perform at Oppenheimer... NuStar Energy (NS) upgraded to Buy from Neutral at Goldman... NuStar GP Holdings (NSH) upgraded to Neutral from Sell at Goldman... Selective Insurance (SIGI) upgraded to Outperform from Market Perform at Keefe Bruyette... Teva (TEVA) upgraded to Neutral from Underweight at JPMorgan... Turkcell (TKC) upgraded to Buy from Neutral at UBS... Pilgrim's Pride (PPC) upgraded to Overweight from Equal Weight at Stephens... Tesco (TESO) upgraded to Overweight from Equalweight at Capital One.
News For BANC;INDB;LOW;NS;NSH;SIGI;TEVA;TKC;PPC;TESO From The Last 14 Days
Check below for free stories on BANC;INDB;LOW;NS;NSH;SIGI;TEVA;TKC;PPC;TESO the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
August 19, 2014
15:16 EDTLOWNotable companies reporting before tomorrow's open
Subscribe for More Information
13:21 EDTLOWEarnings Preview: Lowe's trading higher ahead of Q2 earnings report
Lowe's Companies (LOW), a home improvement retailer, is scheduled to report on its second quarter before the market open on Wednesday, August 20, with a conference call scheduled for 9:00 am ET. EXPECTATIONS: Analysts are looking for earnings per share of $1.02 on revenue of $16.55B, according to First Call. The consensus range for EPS is 96c-$1.06 on revenue of $16.16B-$16.79B. LAST QUARTER: Lowe's reported first quarter EPS of 61c, beating analyst's estimates of 60c, on revenue of $13.4B against estimates for $13.86B. The company also reported Q1 same-store sales rose 0.9%. Lowe's raised its fiscal year 2014 EPS guidance to approximately $2.63 from $2.60 against estimates at that time for $2.62 and said it expects revenue up 5% in this fiscal year compared to last. Lowe's said it expected to open 10 home improvement and 5 hardware stores in 2014 and expects its FY14 SSS to increase approximately 4%. The company expects to repurchase $3.4B of stock this fiscal year. NEWS: During the quarter, Lowe's named Paul Ramsay as Chief Information Officer. The company also raised its quarterly dividend 27.8% to 23c per share. STREET RESEARCH: Deutsche Bank lowered its estimates for both Lowe's and Home Depot (HD) after Tractor Supply (TSCO) and Lumber Liquidators (LL) pre-announced Q2 comp misses. The firm, which noted that the negative earnings revision is "relatively minor," said that while the business models are different, Tractor Supply and Lumber Liquidators have historically correlated positively with Home Depot and Lowe's on comps. Morgan Stanley initiated Lowe's with an Equal Weight rating and $50 target in June. Canaccord downgraded Lowe's to Sell from Hold due to slowing housing momentum, management changes, and difficult competition. PRICE ACTION: Over the last three months, Lowe's shares are up almost 14%. In morning trading ahead of tomorrow's report, Lowe's is up nearly 3% to $51.89.
11:41 EDTLOWHome Depot rises as results beat estimates, company raises guidance
Subscribe for More Information
07:09 EDTNSH, NSCitigroup to hold a conference
MLP / Midstream Infrastructure Conference to be held in Las Vegas on August 19-21.
05:11 EDTTEVAGamida Cell announces investment, option agreement with Novartis
Subscribe for More Information
August 18, 2014
11:25 EDTLOWEarnings Preview: Home Depot shares up nearly 9% since last earnings report
Home Depot (HD), a home improvement retailer, is scheduled to report second quarter results before the market opens on Tuesday, August 19, with a conference call scheduled for 9:00 am ET. EXPECTATIONS: Analysts are looking for earnings per share of $1.45 on revenue of $23.62B, according to First Call. The consensus range for EPS is $1.41-$1.49 on revenue of $22.9B-$24.08B. LAST QUARTER: Home Depot reported first quarter EPS of $1.00 against estimates for 99c on revenue of $19.69B against estimates of $19.95B. The company said same-store sales increased 2.6%, with U.S. SSS up 3.3%. The company raised its fiscal year 2014 EPS view to $4.42 from $4.38 against estimates at that time for $4.42. The retailer also backed its FY14 sales growth view of up 4.8% from fiscal year 2013. On its Q4 earnings conference call, Home Depot forecast gross margins for FY14 would be "about the same" as last year. For the remainder of the year, the company said its view on the housing market recovery had not changed. NEWS: At Oppenheimer's 14th Annual Consumer Conference in June, Home Depot reaffirmed its 4.8% sales growth view for the year and said SSS growth would be 4.6%. The company also said it expected $7B in share repurchases for FY14. The retailer also said it intends to increase its dividend every year. The Wall Street Journal said Home Depot is among the retailers betting that consumer basics, like toilet paper or detergent, will increase sales and lure shoppers into stores. STREET RESEARCH: Citigroup expects Home Depot shares will continue outperforming Lowe's (LOW) in the near-term given its store base concentration and better merchandising effort on the Pro side. Deutsche Bank lowered its estimates for both Home Depot after Tractor Supply (TSCO) and Lumber Liquidators (LL) pre-announced Q2 comp misses. The firm, which noted that the negative earnings revision is "relatively minor," said that while the business models are different, Tractor Supply and Lumber Liquidators have historically correlated positively with Home Depot and Lowe's on comps. PRICE ACTION: Over the last three months, Home Depot shares are up almost 9%. Year-to-date, shares are up over 2%.
10:06 EDTTEVALannett surges after upbeat Q4, FY14 outlook
Subscribe for More Information
08:50 EDTTEVATeva management to meet with JPMorgan
Meeting to be held in Boston on August 20 hosted by JPMorgan.
06:24 EDTLOWOptions expected to be active
Subscribe for More Information
August 14, 2014
17:08 EDTTEVASoros Fund Management gives quarterly update on stakes
NEW STAKES: CONSOL Energy (CNX), Google (GOOG), Level 3 (LVLT), Time Warner (TWC), and New Oriental (EDU). INCREASED STAKES: YPF SA (YPF), Apple (AAPL), Facebook (FB), AIG (AIG), and American Airlines (AAL). DECREASED STAKES: Teva (TEVA), Liberty Global (LBTYK), Barrick Gold (ABX), EQT (EQT), and Comcast (CMCSA). LIQUIDATED STAKES: FedEx (FDX), Monster Beverage (MNST), Google (GOOGL), Devon Energy (DVN), Marathon Petroleum (MPC).
12:58 EDTTEVAJANA Partners gives quarterly update on stakes
NEW STAKES: Apache (APA), FMC Corp (FMC), Civeo (CVEO), PetSmart (PETM), and Charter Communications (CHTR). INCREASED STAKES: Actavis (ACT), AIG (AIG), Mallinckrodt (MNK), HD Supply (HDS), and American Capital (ACAS). DECREASED STAKES: Liberty (LVNTA), Oil States International (OIS), eBay (EBAY), Liberty Media (LMCA), and Liberty Interactive (LINTA). LIQUIDATED STAKES: Sirius XM (SIRI), Juniper (JNPR), Golar LNG (GLNG), Outerwall (OUTR), and Teva (TEVA).
August 11, 2014
15:42 EDTLOWLowe's August volatility flat into Q2 and outlook
Subscribe for More Information
August 8, 2014
09:36 EDTINDBIndependent Bank upgraded to Buy from Hold at Sandler O'Neill
Subscribe for More Information
August 7, 2014
13:55 EDTTEVATeva won't be meaningfully hurt soon by new Copaxone filing, says BMO Capital
After Teva (TEVA) confirmed that it received the first paragraph IV notice for the 3x per week version of its Copaxone drug from Dr. Reddy's (RDY), BMO Capital said it had expected companies to seek to market a generic version of the latest Copaxone formulation, but was surprised that Dr. Reddy's took this action. The firm notes that Teva's decision to file a lawsuit against Dr. Reddy over the application will trigger a 30 month stay of approval of the generic version,. BMIO Capital says that investors should keep this issue on their radar, but the firm does not expect Teva to be meaningfully hurt in the near-term by this development. It keeps an Outperform rating on Teva.
12:06 EDTTEVATeva will continue to defend COPAXONE intellectual property rights
Teva (TEVA) confirmed that it has received the first paragraph IV notice for its three-times-a-week COPAXONE 40 mg/mL product from Dr. Reddy’s Laboratories (RDY). Teva will continue to vigorously defend its COPAXONE intellectual property rights against infringement wherever they are challenged. Teva intends to file a lawsuit for patent infringement against Dr. Reddy’s within the 45 day period provided under the Hatch-Waxman Act. The filing of the lawsuit will trigger a 30 month stay of FDA approval of Dr. Reddy’s ANDA. COPAXONE 40 mg/mL is protected by two Orange Book patents that expire in 2030.
11:34 EDTPPCRussia retaliates with restrictions on U.S. chicken imports, CNN says
Subscribe for More Information
10:20 EDTTEVAMylan says litigation ins ongoing in India regarding Teva
Mylan (MYL) said that it expects Teva's (TEVA) efforts to seek an injunction will "as ineffective as it was in U.S. courts." The company said it will not provide further comment on the matter. Mylan said it will also postpone its 2014 Investor Day due to the ongoing nature of the Abbott (ABT) transaction. It expects its fully realized savings and profit from new products will not be realized till 2015. Comments taken from Q2 earnings conference call.
10:00 EDTINDBOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
06:20 EDTLOWHome Depot should continue outperforming Lowe's, says Citigroup
Subscribe for More Information
06:08 EDTINDBIndependent Bank upgraded to Buy from Neutral at Guggenheim
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use